ReconfigBehSci. (2020, November 9). RT @peterbachmd: Relevant today: Ever sharp @nataliexdean on Vaccine Effectiveness vs Efficacy from many moons ago (i.e. About a month). Sh… [Tweet]. @SciBeh. https://twitter.com/SciBeh/status/1325889181097267200

As vaccines start rolling out, here’s what our research says about communication and coronavirus. (n.d.). Reuters Institute for the Study of Journalism. Retrieved 13 January 2021, from https://reutersinstitute.politics.ox.ac.uk/risj-review/vaccines-start-rolling-out-heres-what-our-research-says-about-communication-and

US pharmacist who tried to ruin Covid vaccine doses is a conspiracy theorist, police say. (2021, January 5). The Guardian. http://www.theguardian.com/us-news/2021/jan/04/wisconsin-pharmacist-covid-19-vaccine-doses-steven-brandenburg

What is vaccine hesitancy and why do so many people have it? (n.d.). Vogue India. Retrieved 13 January 2021, from https://www.vogue.in/wellness/content/what-is-vaccine-hesitancy-and-why-do-so-many-people-have-it

US pharmacist who tried to ruin Covid vaccine doses is a conspiracy theorist, police say. (2021, January 5). The Guardian. http://www.theguardian.com/us-news/2021/jan/04/wisconsin-pharmacist-covid-19-vaccine-doses-steven-brandenburg

Marsh, S. (2020, December 4). Vaccine expert tells ministers: ‘Stop boasting and get public onboard’. The Guardian. https://www.theguardian.com/politics/2020/dec/04/advice-to-uk-ministers-stop-vaccine-boasting-and-get-public-onboard

Zhang, S. (2020, May 24). We Don’t Even Have a COVID-19 Vaccine, and Yet the Conspiracies Are Here. The Atlantic. https://www.theatlantic.com/science/archive/2020/05/covid-19-vaccine-skeptics-conspiracies/611998/

Zhang, S. (2020, September 28). Vaccine Chaos Is Looming. The Atlantic. https://www.theatlantic.com/health/archive/2020/09/covid-19-most-complicated-vaccine-campaign-ever/616521/

Zhang, S. (2020, November 10). The Lame-Duck Vaccine. The Atlantic. https://www.theatlantic.com/health/archive/2020/11/bidens-vaccine-reset/617059/

Zhang, S. (2020, December 1). The Long Haul of Vaccine Results Is Just Beginning. The Atlantic. https://www.theatlantic.com/health/archive/2020/12/vaccine-trials-can-still-surprise-us/617247/

Zhang, S. (2020, November 18). The End of the Pandemic Is Now in Sight. The Atlantic. https://www.theatlantic.com/health/archive/2020/11/vaccines-end-covid-19-pandemic-sight/617141/

Sridhar, D. (2020, November 16). It’s not just the vaccine. There are many causes for hope in the fight against Covid | Devi Sridhar. The Guardian. https://www.theguardian.com/commentisfree/2020/nov/16/vaccine-hope-fight-covid-tests-treatments

Cyranoski, D. (2020). Arab nations first to approve Chinese COVID vaccine—Despite lack of public data. Nature, 588(7839), 548–548. https://doi.org/10.1038/d41586-020-03563-z

Ledford, H., Cyranoski, D., & Noorden, R. V. (2020). The UK has approved a COVID vaccine—Here’s what scientists now want to know. Nature, 588(7837), 205–206. https://doi.org/10.1038/d41586-020-03441-8

Katy Milkman on how to nudge people to accept a covid-19 vaccine. (2020, November 30). The Economist. https://www.economist.com/by-invitation/2020/11/30/katy-milkman-on-how-to-nudge-people-to-accept-a-covid-19-vaccine

Grover, N. (2020, December 7). WHO looks at giving Covid-19 to healthy people to speed up vaccine trials. The Guardian. https://www.theguardian.com/world/2020/dec/07/who-looks-at-giving-covid-to-healthy-people-to-speed-up-vaccine-trials

BNT162b2

How We Can Stop the Spread of Coronavirus by Christmas. (n.d.). Time. Retrieved December 17, 2020, from https://time.com/5912705/covid-19-stop-spread-christmas/

Is this expectation higher than for other coronavirus vaccines? MHRA: Medicines & Healthcare products Regulatory Agency

Ledford, H. (2020). Oxford COVID-vaccine paper highlights lingering unknowns about results. Nature. https://doi.org/10.1038/d41586-020-03504-w

Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., Bibi, S., Briner, C., Cicconi, P., Collins, A. M., Colin-Jones, R., Cutland, C. L., Darton, T. C., Dheda, K., Duncan, C. J. A., … Zuidewind, P. (2020). Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet, 0(0). https://doi.org/10.1016/S0140-6736(20)32661-1

Karl Friston and Anthony Costello: What we have learned from the second covid-19 surge? (2020, December 8). The BMJ. https://blogs.bmj.com/bmj/2020/12/08/karl-friston-and-anthony-costello-what-we-have-learned-from-the-second-covid-19-surge/

Serhan, Y. (2020, December 8). Vaccine Nationalism Is Doomed to Fail. The Atlantic. https://www.theatlantic.com/international/archive/2020/12/vaccine-nationalism-doomed-fail/617323/

A Marm Kilpatrick. (2020, December 8). FDA Pfizer/BioNTech vaccine efficacy results are great, but aren’t nearly as great as presented for severe infections. Everyone has seen fig below on cases in vaccine (blue) & placebo (red) over time. Thread. Https://t.co/vlZyZgJ7hr https://t.co/9ZWeWCko1x [Tweet]. @DiseaseEcology. https://twitter.com/DiseaseEcology/status/1336446195284070400

Coronavirus (COVID-19) vaccine. (2020, November 26). Nhs.Uk. https://www.nhs.uk/conditions/coronavirus-covid-19/coronavirus-vaccination/coronavirus-vaccine/

NHS told not to give Covid vaccine to those with history of allergic reactions. (2020, December 9). The Guardian. http://www.theguardian.com/world/2020/dec/09/pfizer-covid-vaccine-nhs-extreme-allergy-sufferers-regulators-reaction

Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study | Moderna, Inc. (n.d.). Retrieved 1 December 2020, from https://investors.modernatx.com/news-releases/news-release-details/modernas-covid-19-vaccine-candidate-meets-its-primary-efficacy/

CohenNov. 16, J., 2020, & Am, 7:00. (2020, November 16). ‘Just beautiful’: Another COVID-19 vaccine, from newcomer Moderna, succeeds in large-scale trial. Science | AAAS. https://www.sciencemag.org/news/2020/11/just-beautiful-another-covid-19-vaccine-newcomer-moderna-succeeds-large-scale-trial

COVID-19: The 9/11 Moment for Global Public Health? Dr. Richard Horton and Clive Cookson. (2020, September 1). https://www.youtube.com/watch?v=97iJIwBQ5qE&feature=youtu.be

Global Covid report: Young and healthy may not get vaccine until 2022, WHO says. (2020, October 15). The Guardian. http://www.theguardian.com/world/2020/oct/15/global-covid-report-young-and-healthy-may-not-get-vaccine-until-2022-who-says

Aubrey, A. (2020). Will Kids Get A COVID-19 Vaccine? Pfizer To Expand Trial To Ages 12 And Up. NPR. https://www.npr.org/sections/health-shots/2020/10/13/923248377/will-kids-get-a-covid-19-vaccine-pfizer-to-expand-trial-to-ages-12-and-up?t=1602805163253

Nouri, A. B., Ali. (n.d.). COVID Misinformation Is Killing People. Scientific American. Retrieved October 12, 2020, from https://www.scientificamerican.com/article/covid-misinformation-is-killing-people1/

NW, 1615 L. St, Suite 800Washington, & Inquiries, D. 20036USA202-419-4300 | M.-857-8562 | F.-419-4372 | M. (2020, September 17). U.S. Public Now Divided Over Whether To Get COVID-19 Vaccine. Pew Research Center Science & Society. https://www.pewresearch.org/science/2020/09/17/u-s-public-now-divided-over-whether-to-get-covid-19-vaccine/

Horton, R. (2020). Offline:Reasons for hope. Lancet, 396

Nkengasong, J. N., Ndembi, N., Tshangela, A., & Raji, T. (2020). COVID-19 vaccines: How to ensure Africa has access. Nature, 586(7828), 197–199. https://doi.org/10.1038/d41586-020-02774-8

Bingham, K. (2020). Plan now to speed vaccine supply for future pandemics. Nature, 586(7828), 171–171. https://doi.org/10.1038/d41586-020-02798-0

Haseltine, W. A. (n.d.). Lessons from AIDS for the COVID-19 Pandemic. Scientific American. https://doi.org/10.1038/scientificamerican1020-35

Natalie E. Dean en Twitter: “VACCINE EFFICACY 101: A biostatistician's primer. Ten tweets to cover:- How is vaccine efficacy calculated?- Distinguishing between infection, disease, & severe disease.- Measuring reduced infectiousness.- Vaccine efficacy vs. effectiveness!n” / Twitter. (n.d.). Twitter. Retrieved September 30, 2020, from https://twitter.com/nataliexdean/status/1310613702476017666

Stephen Griffin on Twitter. (n.d.). Twitter. Retrieved September 2, 2020, from https://twitter.com/SGriffin_Lab/status/1300572439374630917

Over 250,000 volunteers now registered for new COVID-19 vaccine trials as recruitment begins for Novavax study. (n.d.). Retrieved September 28, 2020, from https://www.nihr.ac.uk/news/over-250000-volunteers-now-registered-for-new-covid-19-vaccine-trials-as-recruitment-begins-for-novavax-study/25731

Pausal Živference on Twitter. (n.d.). Twitter. Retrieved September 26, 2020, from https://twitter.com/PausalZ/status/1309208611265093632

Beware comforting lies about a “herd immunity” Covid-19 strategy. Here’s why it’s dangerous – Professor Devi Sridhar. (n.d.). Retrieved September 25, 2020, from https://www.scotsman.com/news/opinion/columnists/covid-19-herd-immunity-strategy-flawed-until-we-have-coronavirus-vaccine-professor-devi-sridhar-2981017

Leask, Julie. ‘Vaccines — Lessons from Three Centuries of Protest’. Nature 585, no. 7826 (21 September 2020): 499–501. https://doi.org/10.1038/d41586-020-02671-0.

If rich countries monopolize COVID-19 vaccines, it could cause twice as many deaths as distributing them equally. (n.d.). Retrieved September 17, 2020, from https://news.northeastern.edu/2020/09/14/if-rich-countries-monopolize-covid-19-vaccines-it-could-cause-twice-as-many-deaths-as-distributing-them-equally/

Duquette, N. (2020). Heard immunity: Effective persuasion for a future COVID-19 vaccine. https://doi.org/10.31235/osf.io/jwvsp

magazine, D. C., Smriti Mallapaty,Nature. (n.d.). Coronavirus Vaccine U.K. Trial Restarts, But Scientists Question Lack of Transparency. Scientific American. Retrieved September 16, 2020, from https://www.scientificamerican.com/article/coronavirus-vaccine-u-k-trial-restarts-but-scientists-question-lack-of-transparency/

Public trust in vaccines rises in most of Europe, study says. (2020). Financial Times. Retrieved September 16, 2020, from https://www.ft.com/content/fd3264ea-dc97-489e-969f-a933288babbe

Lewis, T. (n.d.). Nine COVID-19 Myths That Just Won’t Go Away. Scientific American. Retrieved September 11, 2020, from https://www.scientificamerican.com/article/nine-covid-19-myths-that-just-wont-go-away/

Diseases, T. L. I. (2020). Curing COVID-19. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(20)30706-4

Emanuel, E. J., & Offit, P. A. (2020, June 8). Opinion | Could Trump Turn a Vaccine Into a Campaign Stunt? The New York Times. https://www.nytimes.com/2020/06/08/opinion/trump-coronavirus-vaccine.html

News, A. B. C. (n.d.). Getting COVID-19 and the flu at the same time: What are the risks? ABC News. Retrieved September 2, 2020, from https://abcnews.go.com/Health/covid-19-flu-time-risks/story?id=72520950

editor, S. B. H. (2020, August 30). Covid vaccine rush could make pandemic worse, say scientists. The Guardian. https://www.theguardian.com/society/2020/aug/30/covid-vaccine-rush-could-make-pandemic-worse-say-scientists

Hurst, D., & Murphy, K. (2020, June 22). Trump’s misleading information enables China to sow discord among allies, research finds. The Guardian. https://www.theguardian.com/australia-news/2020/jun/23/trumps-misleading-information-enables-china-to-sow-discord-among-allies-research-finds

Senior, J. (2020, July 21). Opinion | I Spoke With Anthony Fauci. He Says His Inbox Isn’t Pretty. The New York Times. https://www.nytimes.com/2020/07/21/opinion/anthony-fauci-coronavirus.html

Hoffman, J. (2020, August 16). Fearing a ‘Twindemic,’ Health Experts Push Urgently for Flu Shots. The New York Times. https://www.nytimes.com/2020/08/16/health/coronavirus-flu-vaccine-twindemic.html

Heywood, A. E., & Macintyre, C. R. (2020). Elimination of COVID-19: What would it look like and is it possible? The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(20)30633-2

Felipe, L. S., Vercruysse, T., Sharma, S., Ma, J., Lemmens, V., Looveren, D. van, Javarappa, M. P. A., Boudewijns, R., Malengier-Devlies, B., Kaptein, S. F., Liesenborghs, L., Keyzer, C. D., Bervoets, L., Rasulova, M., Seldeslachts, L., Jansen, S., Yakass, M. B., Quaye, O., Li, L.-H., … Dallmeier, K. (2020). A single-dose live-attenuated YF17D-vectored SARS-CoV2 vaccine candidate. BioRxiv, 2020.07.08.193045. https://doi.org/10.1101/2020.07.08.193045

LeslieMay. 14, M., 2020, & Pm, 9:00. (2020, May 14). T cells found in COVID-19 patients ‘bode well’ for long-term immunity. Science | AAAS. https://www.sciencemag.org/news/2020/05/t-cells-found-covid-19-patients-bode-well-long-term-immunity

Rahvy, A., & Ridlo, I. A. (2020). A Timeline Response: How Does Islamic Organizations Respond to COVID-19 in Indonesia? https://doi.org/10.31235/osf.io/kzhy9

Zhu, F.-C., Guan, X.-H., Li, Y.-H., Huang, J.-Y., Jiang, T., Hou, L.-H., Li, J.-X., Yang, B.-F., Wang, L., Wang, W.-J., Wu, S.-P., Wang, Z., Wu, X.-H., Xu, J.-J., Zhang, Z., Jia, S.-Y., Wang, B.-S., Hu, Y., Liu, J.-J., … Chen, W. (2020). Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: A randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet, 0(0). https://doi.org/10.1016/S0140-6736(20)31605-6

Corbett, K. S., Edwards, D. K., Leist, S. R., Abiona, O. M., Boyoglu-Barnum, S., Gillespie, R. A., Himansu, S., Schäfer, A., Ziwawo, C. T., DiPiazza, A. T., Dinnon, K. H., Elbashir, S. M., Shaw, C. A., Woods, A., Fritch, E. J., Martinez, D. R., Bock, K. W., Minai, M., Nagata, B. M., … Graham, B. S. (2020). SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature, 1–8. https://doi.org/10.1038/s41586-020-2622-0

Walls, A. C., Fiala, B., Schäfer, A., Wrenn, S., Pham, M. N., Murphy, M., Tse, L. V., Shehata, L., O’Connor, M. A., Chen, C., Navarro, M. J., Miranda, M. C., Pettie, D., Ravichandran, R., Kraft, J. C., Ogohara, C., Palser, A., Chalk, S., Lee, E.-C., … King, N. P. (2020). Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2. BioRxiv, 2020.08.11.247395. https://doi.org/10.1101/2020.08.11.247395

Nature. (2020, April 17). Coronapod: Troubling news. https://play.acast.com/s/nature/coronapod-troublingnews

Barber, C. (n.d.). ‘Instant Coffee’ COVID-19 Tests Could Be the Answer to Reopening the U.S. Scientific American. Retrieved August 27, 2020, from https://www.scientificamerican.com/article/instant-coffee-covid-19-tests-could-be-the-answer-to-reopening-the-u-s/

Science Facebook Live: Understanding SARS-CoV-2 structure informs vaccine design, clinical trials. (2020, March 20). https://www.youtube.com/watch?v=nOzEx3OpKe8

University, © Stanford, Stanford, & Complaints, C. 94305 C. (n.d.). Virality Project (US): Marketing meets Misinformation. Retrieved 25 August 2020, from https://cyber.fsi.stanford.edu/io/news/manufacturing-influence-0

Daas, Chantal den, Gill Hubbard, Marie Johnston, and Diane Dixon. ‘Protocol CHARIS Study’. Preprint. PsyArXiv, 19 August 2020. https://doi.org/10.31234/osf.io/jnxcu.

‘Missing School Is “Worse than Virus for Children”’. BBC News, 23 August 2020, sec. UK. https://www.bbc.com/news/uk-53875410.

Sun, W., McCroskery, S., Liu, W.-C., Leist, S. R., Liu, Y., Albrecht, R. A., Slamanig, S., Oliva, J., Amanat, F., Schäfer, A., Dinnon, K. H., Innis, B. L., García-Sastre, A., Krammer, F., Baric, R. S., & Palese, P. (2020). A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine. BioRxiv, 2020.07.30.229120. https://doi.org/10.1101/2020.07.30.229120

Bangaru, S., Ozorowski, G., Turner, H. L., Antanasijevic, A., Huang, D., Wang, X., Torres, J. L., Diedrich, J. K., Tian, J.-H., Portnoff, A. D., Patel, N., Massare, M. J., Yates, J. R., Nemazee, D., Paulson, J. C., Glenn, G., Smith, G., & Ward, A. B. (2020). Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate. BioRxiv, 2020.08.06.234674. https://doi.org/10.1101/2020.08.06.234674

Ledford, H. (2020). What the immune response to COVID-19 says about the prospects for a vaccine. Nature. https://doi.org/10.1038/d41586-020-02400-7

Marshall, M. (n.d.). Everything you need to know about Russia’s coronavirus vaccine claims. New Scientist. Retrieved August 18, 2020, from https://www.newscientist.com/article/2251722-everything-you-need-to-know-about-russias-coronavirus-vaccine-claims/

Lo, A. W., Siah, K. W., & Wong, C. H. (2020). Estimating Probabilities of Success of Vaccine and Other Anti-Infective Therapeutic Development Programs (Working Paper No. 27176; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27176

CNN, A. V., Holly Yan and Christina Maxouris. (n.d.). FDA won’t ‘cut corners’ to approve a Covid-19 vaccine, commissioner says. CNN. Retrieved 12 August 2020, from https://www.cnn.com/2020/08/10/health/us-coronavirus-monday/index.html

CNN, C. M. (n.d.). Previous vaccines and masks may hold down Covid-19, some researchers say. CNN. Retrieved 12 August 2020, from https://www.cnn.com/2020/08/11/health/us-coronavirus-tuesday/index.html

Yong, Ed. ‘Immunology Is Where Intuition Goes to Die’. The Atlantic, 5 August 2020. https://www.theatlantic.com/health/archive/2020/08/covid-19-immunity-is-the-pandemics-central-mystery/614956/.

Hong, H., Wang, N., & Yang, J. (2020). Implications of Stochastic Transmission Rates for Managing Pandemic Risks (Working Paper No. 27218; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27218